跳至主要内容
临床试验/NL-OMON49620
NL-OMON49620已完成不适用

The PaPa Trial: Paracetamol as an adjunct to intrapartum Remifentanil/PCA. An RCT of multimodal pain management during labor. - The PaPa Trial

Reinier de Graaf Groep0 个研究点目标入组 79 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
79

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Pregnant, in labour, >3 centimetres dilatation.
  • Pain request during labour, medication of choice: Remifentanil/ PCA.
  • Age 18 years and older.
  • Able to understand the written and verbal information about the PaPa Trial.

排除标准

  • Refusal for participation in the PaPa Trial
  • No adequate communication possible (e.g. language barrier)
  • Use of other opioids, e.g. Pethidine of epidural analgesia <4 hours prior to
  • start of Remifentanil as pain management.
  • Hypersensitivity for Paracetamol.
  • Liver- of kidneydiseases
  • Alcohol abuse
  • Glucose-6-phosphate dehydrogenase
  • Use of other medication that contains Acetaminophen/ Paracetamol
  • Severe nutritional deficiency

研究者

发起方
Reinier de Graaf Groep

相似试验

The PaPa Trial: Paracetamol as an adjunct to... | 临床试验